Literature DB >> 9259108

Degradation of human factor XIII by lonomin V, a purified fraction of Lonomia achelous caterpillar venom.

B A Guerrero1, C L Arocha-Piñango, A Gil San Juan.   

Abstract

Lonomia achelous caterpillar venom (LACV) causes a severe bleeding diathesis in humans. A constant finding in these cases is a profound depression of blood clotting Factor XIII (FXIII) activity. The molecular mechanisms by which LONOMIN V (a chromatographically purified fraction from LACV) alters the FXIII complex is the subject of the present study. Incubation of human purified FXIII with Lonomin V shows that both the zymogen and the activated forms of FXIII were proteolytically degraded, with the generation of peptidic fragments of low molecular weight. Both the A and B subunits of FXIII were degraded in a progressive, dose dependent manner. The B subunit was more resistant to the action of Lonomin V, requiring higher concentrations in order to achieve complete degradation. On the basis of these findings we postulate that the proteolysis of FXIII in vivo is one of the pathophysiological factors behind this bleeding syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259108     DOI: 10.1016/s0049-3848(97)00117-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Hemostatic disorders induced by skin contact with Lonomia obliqua (Lepidoptera, Saturniidae) caterpillars.

Authors:  Ida Sigueko Sano-Martins; Alaour Candida Duarte; Belsy Guerrero; Roberto Henrique Pinto Moraes; Elvino José Guardão Barros; Carmen Luisa Arocha-Piñango
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-20       Impact factor: 1.846

2.  Recombinant Destabilase from Hirudo medicinalis Is Able to Dissolve Human Blood Clots In Vitro.

Authors:  Pavel Bobrovsky; Valentin Manuvera; Izolda Baskova; Svetlana Nemirova; Alexandr Medvedev; Vassili Lazarev
Journal:  Curr Issues Mol Biol       Date:  2021-11-20       Impact factor: 2.976

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.